Matrix Capital Management

Portfolio Companies 2026 for Matrix Capital Management: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Matrix Capital Management accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $2.8B. The median disclosed raise is $150M, and the largest is ElevateBio at $1.3B, ahead of Blockdaemon ($400M) and Rivos ($250M).

The names that recur most often on these portfolio cap tables are Matrix Capital Management (10 companies), SoftBank Vision Fund 2 (2 companies), Surveyor Capital (2 companies), NTTVC (2 companies), Mayo Clinic (2 companies), Takeda Ventures (2 companies). By latest disclosed round, the market skews Series C (5), Series D (2), Series B (2), Series A (1).

Best funded Matrix Capital Management companies

  1. ElevateBio — $1.3B (latest: Series D)
  2. Blockdaemon — $400M (latest: Series C)
  3. Rivos — $250M (latest: Series A)
  4. Encoded Therapeutics — $240M (latest: Series D)
  5. nference — $150M (latest: Series C)
  6. Palleon Pharmaceuticals — $147M (latest: Series B)
  7. Bardavon Health Innovations — $122M (latest: Series C)
  8. Anumana — $86M (latest: Series C)
  9. AltPep — $76M (latest: Series B)
  10. Koneksa Health — $65M (latest: Series C)

Matrix Capital Management — related firms and companies (53)

Matrix Capital Management alternatives · All research reports